Advancing Generic Drug Development Translating

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1

Commissioner of Food and

Advancing Generic Drug Development: Translating Science to Approval Keynote Address

Dr. Janet Woodcock, MD, acting Commissioner of Food and

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 2

This public workshop communicated how FDA's

Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks

Lei Zhang, PhD, Deputy Director for the Office of Regulatory Science, delivers closing remarks to conclude day one of...

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 3

This public workshop communicated how FDA's

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 1

This public workshop communicated how FDA's

Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2

This workshop focused on common issues seen in abbreviated new

Advancing Generic Drug Development: Translating Science to Approval, Day Two Closing Remarks

Robert Lionberger, PhD, Director for the Office of Regulatory Science, delivers closing remarks to conclude the

Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 1

FDA experts demonstrate the FDA's

Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2

The purpose of this public workshop is to communicate how FDA's

Advancing Generic Drug Development: Translating Science to Approval - Day 1 – Keynote and Session 1

This workshop focused on common issues seen in abbreviated new

Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 7

This workshop focused on common issues seen in abbreviated new

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 3

This public workshop communicated how FDA's